These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 25510578)
1. Management of de novo malignancies after liver transplantation. Pillai AA Transplant Rev (Orlando); 2015 Jan; 29(1):38-41. PubMed ID: 25510578 [TBL] [Abstract][Full Text] [Related]
2. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients. Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102 [TBL] [Abstract][Full Text] [Related]
3. Burden of de novo malignancy in the liver transplant recipient. Chandok N; Watt KD Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database. Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501 [TBL] [Abstract][Full Text] [Related]
5. De novo malignancies after liver transplantation: a major cause of late death. Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783 [TBL] [Abstract][Full Text] [Related]
6. New concepts and best practices for management of pre- and post-transplantation cancer. Campistol JM; Cuervas-Mons V; Manito N; Almenar L; Arias M; Casafont F; Del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Román A; Serón D; Ussetti P; Transplant Rev (Orlando); 2012 Oct; 26(4):261-79. PubMed ID: 22902168 [TBL] [Abstract][Full Text] [Related]
7. Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879 [TBL] [Abstract][Full Text] [Related]
8. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients. Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495 [TBL] [Abstract][Full Text] [Related]
9. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287 [TBL] [Abstract][Full Text] [Related]
10. De novo malignancy post-liver transplantation: a single center, population controlled study. Chatrath H; Berman K; Vuppalanchi R; Slaven J; Kwo P; Tector AJ; Chalasani N; Ghabril M Clin Transplant; 2013; 27(4):582-90. PubMed ID: 23808800 [TBL] [Abstract][Full Text] [Related]
11. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349 [TBL] [Abstract][Full Text] [Related]
12. De Novo Malignancies After Transplantation: Risk and Surveillance Strategies. Doycheva I; Amer S; Watt KD Med Clin North Am; 2016 May; 100(3):551-67. PubMed ID: 27095645 [TBL] [Abstract][Full Text] [Related]
13. De novo malignancies following liver transplantation: impact and recommendations. Herrero JI Liver Transpl; 2009 Nov; 15 Suppl 2():S90-4. PubMed ID: 19877025 [TBL] [Abstract][Full Text] [Related]
14. Posttransplant malignancies in liver transplant recipients. Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818 [TBL] [Abstract][Full Text] [Related]
16. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091 [TBL] [Abstract][Full Text] [Related]
17. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037 [TBL] [Abstract][Full Text] [Related]
18. Long-term care of transplant recipients: de novo neoplasms after liver transplantation. Burra P; Shalaby S; Zanetto A Curr Opin Organ Transplant; 2018 Apr; 23(2):187-195. PubMed ID: 29324517 [TBL] [Abstract][Full Text] [Related]
19. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients. Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of de novo malignancies after solid-organ transplantation: immunosuppression, infection and other risk factors. Piselli P; Verdirosi D; Cimaglia C; Busnach G; Fratino L; Ettorre GM; De Paoli P; Citterio F; Serraino D Best Pract Res Clin Obstet Gynaecol; 2014 Nov; 28(8):1251-65. PubMed ID: 25209964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]